Acebutolol is a cardioselective, beta-adrenoreceptor blocking agent, which possesses mild intrinsic sympathomimetic activity (ISA) in its therapeutically effective dose range. In general, beta-blockers reduce the work the heart has to do and allow it to beat more regularly.

Acebutolol is a cardioselective beta-1 blocker and has intrinsic sympathetic activity. It is commonly used in the treatment of angina. It was patented in 1967 and approved for medical use in 1973.

Acebutolol is a cardioselective beta-blocker used in the treatment of hypertension, angina pectoris and cardiac arrhythmias. Acebutolol has been linked to several instances of clinically apparent drug induced liver injury.

Acebutolol is a new hydrophilic, cardioselective beta-adrenergic-blocking agent that possesses partial agonist and membrane-stabilizing activities. In the treatment of mild to moderate essential hypertension, once-daily acebutolol as monotherapy provides effective control …

Feb 17, 2020 · Includes Acebutolol indications, dosage/administration, pharmacology, mechanism/onset/duration of action, half-life, dosage forms, interactions, warnings, adverse reactions, off-label uses and more.

Jun 12, 2024 · Find patient medical information for Acebutolol (Sectral) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Acebutolol is a cardioselective beta-adrenoceptor blocking drug possessing both partial agonist (intrinsic sympathomimetic) and membrane stabilising activity.

Apr 28, 2023 · Acebutolol is a beta blocker that is cardioselective and mainly treats hypertension and arrhythmias. It is a beta-adrenergic antagonist that can affect the bronchial receptors. It shows the reverse effect of epinephrine. It blocks beta-1 receptor activity and lowers blood pressure and heart rate.

Find information on Acebutolol (Sectral) in Davis’s Drug Guide including dosage, side effects, interactions, nursing implications, mechanism of action, half life, administration, and more. Davis Drug Guide PDF.

Mechanism of Action. Selectively antagonizes beta-1 adrenergic receptors; Class II antiarrhythmic; Comments See Also References. Acebutolol hydrochloride [prescribing information]. Bridgewater, NJ: Amneal Pharmaceuticals; January 2016